Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.005 GBP
−1.27 M GBP
1.95 K GBP
325.84 M
About N4 PHARMA PLC ORD GBP0.004
Sector
Industry
CEO
Nigel James Theobald
Website
Headquarters
Chellaston
Founded
1979
ISIN
GB00BYW8QM32
FIGI
BBG000BZLC27
N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. It develops and commercializes medicines through its Nuvec delivery system. The company was founded by Nigel James Theobald on July 6, 1979 and is headquartered in Chellaston, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of N4P is 0.625 GBX — it has decreased by −3.85% in the past 24 hours. Watch N4 PHARMA PLC ORD GBP0.004 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange N4 PHARMA PLC ORD GBP0.004 stocks are traded under the ticker N4P.
N4P stock has fallen by −3.85% compared to the previous week, the month change is a 25.00% rise, over the last year N4 PHARMA PLC ORD GBP0.004 has showed a −23.08% decrease.
N4P stock is 16.67% volatile and has beta coefficient of −0.43. Track N4 PHARMA PLC ORD GBP0.004 stock price on the chart and check out the list of the most volatile stocks — is N4 PHARMA PLC ORD GBP0.004 there?
Today N4 PHARMA PLC ORD GBP0.004 has the market capitalization of 2.47 M, it has increased by 4.17% over the last week.
Yes, you can track N4 PHARMA PLC ORD GBP0.004 financials in yearly and quarterly reports right on TradingView.
N4 PHARMA PLC ORD GBP0.004 is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
N4P net income for the last half-year is −454.87 K GBP, while the previous report showed −623.18 K GBP of net income which accounts for 27.01% change. Track more N4 PHARMA PLC ORD GBP0.004 financial stats to get the full picture.
No, N4P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. N4 PHARMA PLC ORD GBP0.004 EBITDA is −1.27 M GBP, and current EBITDA margin is −72.94 K%. See more stats in N4 PHARMA PLC ORD GBP0.004 financial statements.
Like other stocks, N4P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade N4 PHARMA PLC ORD GBP0.004 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So N4 PHARMA PLC ORD GBP0.004 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating N4 PHARMA PLC ORD GBP0.004 stock shows the sell signal. See more of N4 PHARMA PLC ORD GBP0.004 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.